Good afternoon :)
Place Order
Add to Watchlist

Fermenta Biotech Ltd

FERMENTA Share Price

338.953.26% (+10.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹957 cr, stock is ranked 1,496

High Risk

Stock is 4.38x as volatile as Nifty

FERMENTA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹957 cr, stock is ranked 1,496

High Risk

Stock is 4.38x as volatile as Nifty

FERMENTA Performance & Key Metrics

FERMENTA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
12.463.36—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.976.460.64%

FERMENTA Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

FERMENTA Company Profile

Fermenta Biotech Ltd manufactures vitamin D and active pharmaceutical ingredients while providing environmental solutions and renting properties, serving various industries including pharmaceuticals and nutrition.

FERMENTA Similar Stocks (Peers)

Compare with peers Compare with peers 

FERMENTA Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.88
36.88
1Y Return
7.93%
7.93%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.14
23.14
1Y Return
1.58%
1.58%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
59.36
59.36
1Y Return
16.29%
16.29%
Buy Reco %
70.83
70.83
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.28
19.28
1Y Return
0.28%
0.28%
Buy Reco %
55.17
55.17
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
22.21
22.21
1Y Return
13.73%
13.73%
Buy Reco %
44.44
44.44
Compare with Peers

FERMENTA Forecast

FERMENTA Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

FERMENTA

FERMENTA

Income

Balance Sheet

Cash Flow

FERMENTA Income Statement

FERMENTA Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.62%, vs industry avg of 10.22%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.12%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 5.25%, vs industry avg of 20.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue166.81311.01415.82304.03385.54406.66358.54347.47481.30481.30
Raw Materialssubtract82.1085.19105.08106.11163.12146.88131.04104.02359.68359.68
Power & Fuel Costsubtract9.7510.8613.8812.7414.2320.3518.2419.78
Employee Costsubtract30.8439.8353.1850.0358.2262.9758.0058.55
Selling & Administrative Expensessubtract18.6642.7053.1047.5741.0346.1347.5340.65
Operating & Other expensessubtract10.7130.4628.769.0717.9959.83105.4192.19
Depreciation/Amortizationsubtract10.3112.3611.8915.0020.3125.5628.2524.7224.2224.21
Interest & Other Itemssubtract9.9613.6321.2320.0919.0017.9821.3717.4314.1914.19
Taxes & Other Itemssubtract5.8942.2511.26-16.116.1211.50-0.2313.196.346.35
EPS-4.1512.2642.6821.1215.785.31-17.35-7.8426.3526.12
DPS0.210.210.425.002.501.251.251.250.001.25
Payout ratio—0.020.010.240.160.24——0.000.05
See Costs

FERMENTA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Aug 27PDF
Aug 16PDF
Jul 14PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

Feb 13PDF
Nov 23PDF
Sep 22PDF
Jul 8PDF
FY 2020FY 2020

Annual report

PDF

Investor Presentation

Jun 9PDF
Jun 8PDF
Feb 19PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

FERMENTA Stock Peers

FERMENTA Past Performance & Peer Comparison

FERMENTA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Fermenta Biotech Ltd12.463.36—
Sun Pharmaceutical Industries Ltd36.885.56—
Cipla Ltd23.143.901.06%
Torrent Pharmaceuticals Ltd59.3614.95—

FERMENTA Stock Price Comparison

Compare FERMENTA with any stock or ETF
Compare FERMENTA with any stock or ETF
FERMENTA
Loading...

FERMENTA Holdings

FERMENTA Shareholdings

FERMENTA Promoter Holdings Trend

FERMENTA Promoter Holdings Trend

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.02%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

FERMENTA Institutional Holdings Trend

FERMENTA Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

FERMENTA Shareholding Pattern

FERMENTA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding64.09%0.00%0.00%0.02%35.89%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

FERMENTA Shareholding History

FERMENTA Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.05%0.02%0.02%

FERMENTA Insider Trades & Bulk Stock Deals

FERMENTA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing FERMENTA stock

smallcases containing FERMENTA stock

Looks like this stock is not in any smallcase yet.

FERMENTA Events

FERMENTA Events

FERMENTA Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

FERMENTA Dividend Trend

No dividend trend available

FERMENTA Upcoming Dividends

FERMENTA Upcoming Dividends

No upcoming dividends are available

FERMENTA Past Dividends

FERMENTA Past Dividends

Cash Dividend

Ex DateEx DateAug 6, 2024

Final
Final | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Aug 6, 2024

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateAug 4, 2022

Final
Final | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Aug 4, 2022

Cash Dividend

Ex DateEx DateAug 25, 2021

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Aug 25, 2021

Cash Dividend

Ex DateEx DateNov 22, 2019

Interim
Interim | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Nov 22, 2019

FERMENTA Stock News & Opinions

FERMENTA Stock News & Opinions

Corporate
Fermenta Biotech schedules AGM

Fermenta Biotech announced that the Annual General Meeting(AGM) of the company will be held on 12 August 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Fermenta Biotech recommends final dividend

Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter

Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales139.8597.34 44 469.48335.66 40 OPM %26.425.53 -23.398.20 - PBDT37.857.37 414 107.4322.28 382 PBT31.980.91 3414 83.21-2.44 LP NP34.39-6.94 LP 76.86-23.06 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Fermenta Biotech to convene board meeting

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Fermenta Biotech consolidated net profit rises 274.72% in the December 2024 quarter

Net profit of Fermenta Biotech rose 274.72% to Rs 36.91 crore in the quarter ended December 2024 as against Rs 9.85 crore during the previous quarter ended December 2023. Sales rose 58.10% to Rs 156.47 crore in the quarter ended December 2024 as against Rs 98.97 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales156.4798.97 58 OPM %34.0425.38 - PBDT51.4222.46 129 PBT45.3416.07 182 NP36.919.85 275 Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Fermenta Biotech standalone net profit rises 199.15% in the December 2024 quarter

Net profit of Fermenta Biotech rose 199.15% to Rs 35.00 crore in the quarter ended December 2024 as against Rs 11.70 crore during the previous quarter ended December 2023. Sales rose 63.68% to Rs 146.25 crore in the quarter ended December 2024 as against Rs 89.35 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales146.2589.35 64 OPM %34.2829.65 - PBDT48.2723.91 102 PBT42.4517.78 139 NP35.0011.70 199 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Fermenta Biotech announces board meeting date

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Fermenta Biotech reports consolidated net profit of Rs 11.38 crore in the September 2024 quarter

Net profit of Fermenta Biotech reported to Rs 11.38 crore in the quarter ended September 2024 as against net loss of Rs 28.56 crore during the previous quarter ended September 2023. Sales rose 66.98% to Rs 95.03 crore in the quarter ended September 2024 as against Rs 56.91 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales95.0356.91 67 OPM %19.76-24.46 - PBDT17.97-15.70 LP PBT11.82-21.64 LP NP11.38-28.56 LP Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Fermenta Biotech to discuss results

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Fermenta Biotech reports consolidated net loss of Rs 5.82 crore in the June 2024 quarter

Net loss of Fermenta Biotech reported to Rs 5.82 crore in the quarter ended June 2024 as against net profit of Rs 1.83 crore during the previous quarter ended June 2023. Sales declined 5.24% to Rs 78.13 crore in the quarter ended June 2024 as against Rs 82.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales78.1382.45 -5 OPM %1.0213.26 - PBDT0.198.16 -98 PBT-5.932.21 PL NP-5.821.83 PL Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Fermenta Biotech Ltd (FERMENTA) today?

    The share price of FERMENTA as on 8th July 2025 is ₹338.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Fermenta Biotech Ltd (FERMENTA) share?

    The past returns of Fermenta Biotech Ltd (FERMENTA) share are
    • Past 1 week: -2.98%
    • Past 1 month: 0.12%
    • Past 3 months: 25.41%
    • Past 6 months: -21.73%
    • Past 1 year: 63.80%
    • Past 3 years: 76.95%
    • Past 5 years: 26.49%

  3. What are the peers or stocks similar to Fermenta Biotech Ltd (FERMENTA)?

    The peers or stocks similar to Fermenta Biotech Ltd (FERMENTA) include:

  4. What is the market cap of Fermenta Biotech Ltd (FERMENTA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fermenta Biotech Ltd (FERMENTA) is ₹957.47 Cr as of 8th July 2025.

  5. What is the 52 week high and low of Fermenta Biotech Ltd (FERMENTA) share?

    The 52-week high of Fermenta Biotech Ltd (FERMENTA) is ₹449 and the 52-week low is ₹189.

  6. What is the PE and PB ratio of Fermenta Biotech Ltd (FERMENTA) stock?

    The P/E (price-to-earnings) ratio of Fermenta Biotech Ltd (FERMENTA) is 12.46. The P/B (price-to-book) ratio is 3.36.

  7. Which sector does Fermenta Biotech Ltd (FERMENTA) belong to?

    Fermenta Biotech Ltd (FERMENTA) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Fermenta Biotech Ltd (FERMENTA) shares?

    You can directly buy Fermenta Biotech Ltd (FERMENTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.